News
AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...
A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that ...
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in ...
A federal jury in Delaware found that Revance's rival product infringed patents for Allergan's market-leading neurotoxin ...
A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million.
A MUM was terrified her boob job would kill her after it led to a rare disease. Colette Cooper went under the knife in 2014 ...
11h
LittleTechGirl on MSNThe Future of Aesthetics: Top Injectors to Watch in 2025As the aesthetics industry continues to evolve, experienced and highly skilled injectors are pushing the boundaries of n ...
Tepper has repeatedly advocated for change at Allergan. In a letter early this month, the hedge fund manager wrote that a “growing majority” of S&P 500 companies split their CEO and chairman ...
The Allergan saga just became the stuff of George R.R. Martin novels. Besieged by an unlikely alliance between Valeant Pharmaceuticals and Bill Ackman earlier in the year, Allergan refused to ...
Allergan worked alongside Facebook and its agency of record Mediacom, taking existing My Chronic Migraine campaign material and repurposing it for Facebook. The campaign originally launched in 2011 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results